Efficacy of sequential adjuvant chemolipiodolization on hepatocellular carcinoma: Phase II, open labeled, and historical controlled study
Not Applicable
Completed
- Conditions
- Hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000026633
- Lead Sponsor
- Wakayama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 95
Inclusion Criteria
Not provided
Exclusion Criteria
1)History of iodine-based contrast enhancement allergy 2)History of another malignant disease within the past 5 years
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recurrence free survival at two years after hepatectomy
- Secondary Outcome Measures
Name Time Method iver function Recurrence pattern Recurrence free survival at five years after hepatectomy Overall survival at two and five years after hepatectomy